Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Morgan

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Hepatology (Baltimore, Md.)|January 6, 2022
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMarina Serper, Neehar D Parikh, Grace Thiele, et al.
Hepatology (Baltimore, Md.)|August 4, 2025
Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferaseAndrew S Lim, Sheena N Cruz, Aliya Asghar Uddin, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.
Gastroenterology|May 9, 2018
Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled TrialsAlexandre Louvet, Mark R Thursz, Dong Joon Kim, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2016
Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple ComorbiditiesSamuel B Ho, Alexander Monto, Adam Peyton, et al.
The American Journal of Gastroenterology|September 29, 2025
Increasing Goals of Care Discussions Among Veterans With Cirrhosis: A Veterans Health Administration Quality Improvement InitiativeArpan A Patel, Jacqueline G O'Leary, Jasmohan S Bajaj, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trialZachary D Goodman, Anne M Stoddard, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Hepatology (Baltimore, Md.)|January 6, 2022
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMarina Serper, Neehar D Parikh, Grace Thiele, et al.
Hepatology (Baltimore, Md.)|August 4, 2025
Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferaseAndrew S Lim, Sheena N Cruz, Aliya Asghar Uddin, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.
Gastroenterology|May 9, 2018
Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled TrialsAlexandre Louvet, Mark R Thursz, Dong Joon Kim, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2016
Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple ComorbiditiesSamuel B Ho, Alexander Monto, Adam Peyton, et al.
The American Journal of Gastroenterology|September 29, 2025
Increasing Goals of Care Discussions Among Veterans With Cirrhosis: A Veterans Health Administration Quality Improvement InitiativeArpan A Patel, Jacqueline G O'Leary, Jasmohan S Bajaj, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trialZachary D Goodman, Anne M Stoddard, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Pageof 18